help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bevan, S.
Right arrow Articles by Houlston, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bevan, S.
Right arrow Articles by Houlston, R. S.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 8 3701-3704
Copyright © 2001 by The Endocrine Society


Other Original Articles

A Comprehensive Analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in Familial Nonmedullary Thyroid Cancer: Confirmation of Linkage to TCO1

S. Bevan, T. Pal, C. R. Greenberg, H. Green, J. Wixey, G. Bignell, S. A. Narod, W. D. Foulkes, M. R. Stratton and R. S. Houlston

Section of Cancer Genetics, Institute of Cancer Research (S.B., H.G., J.W., G.B., M.R.S., R.S.H.), Sutton, Surrey, United Kingdom SM2 5NG; Department of Medicine, Women’s College Hospital, University of Toronto (T.P., S.A.N.), Toronto, Ontario, Canada; Section of Genetics and Metabolism, Health Sciences Center (C.R.G.), Winnipeg, Manitoba, Canada R3A 1R9; and Departments of Medicine, Oncology and Human Genetics, Montreal General Hospital, and Sir M. B. Davis-Jewish General Hospital, McGill University (W.D.F.), Montréal, Canada H3T 1E2

Address all correspondence and requests for reprints to: Dr. Richard S. Houlston, Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, United Kingdom SM2 5NG. E-mail: r.houlston{at}icr.ac.uk

Abstract

About 5% of nonmedullary thyroid cancer is familial. These familial nonmedullary thyroid cancer cases are characterized by an earlier age of onset, more aggressive phenotype, and in some families a high propensity to benign thyroid disease. Little is known about the genes conferring predisposition to nonmedullary thyroid cancer. Three loci have been identified through genetic linkage: MNG1 on 14q32, TCO1 on 19p13.2, and fPTC on 1p21. In addition to these putative genes, a number of loci represent candidate familial nonmedullary thyroid cancer predisposition genes by virtue of their involvement in sporadic disease (TRKA), their role in benign disease (TSHR), and because they underlie syndromes with a risk of nonmedullary thyroid cancer (PTEN). To evaluate the roles of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer, we have carried out a comprehensive mutation and linkage analysis of these genes in 22 families. One family was linked to chromosome 19q13.2, confirming that TCO1 underlies a subset of familial nonmedullary thyroid cancer. None of the families was linked to MNG1 or fPTC, and there was no evidence to support the roles of PTEN, TSHR, or TRKA. Familial nonmedullary thyroid cancer is an emerging clinical phenotype that is genetically heterogeneous, and none of the currently identified genes accounts for the majority of families.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
M Niedziela
Pathogenesis, diagnosis and management of thyroid nodules in children.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 427 - 453.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J D McKay, D Thompson, F Lesueur, K Stankov, A Pastore, C Watfah, S Strolz, G Riccabona, R Moncayo, G Romeo, et al.
Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer
J. Med. Genet., June 1, 2004; 41(6): 407 - 412.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Matakidou, N. Hamel, S. Popat, K. Henderson, T. Kantemiroff, C. Harmer, S. E.M. Clarke, R. S. Houlston, and W. D. Foulkes
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene
Carcinogenesis, March 1, 2004; 25(3): 369 - 373.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. D. Malchoff and D. M. Malchoff
The Genetics of Hereditary Nonmedullary Thyroid Carcinoma
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2455 - 2459.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society